TY - JOUR
T1 - Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses
T2 - Comparison with B7.1 and 4-1BBL
AU - Serghides, Lena
AU - Bukczynski, Jacob
AU - Wen, Tao
AU - Wang, Chao
AU - Routy, Jean Pierre
AU - Boulassel, Mohamed Rachid
AU - Sekaly, Rafick Pierre
AU - Ostrowski, Mario
AU - Bernard, Nicole F.
AU - Watts, Tania H.
PY - 2005/11/15
Y1 - 2005/11/15
N2 - CTL are important effectors of antiviral immunity. Designing adjuvants that can induce strong cytotoxic T cell responses in humans would greatly improve the effectiveness of an antiviral vaccination or therapeutic strategy. Recent evidence suggests that, in addition to its well-established role in costimulation of CD4 T cell responses, OX40L (CD134) can directly costimulate mouse CD8 T cells. In this study, we evaluated the role of OX40L in costimulation of human antiviral CD8 T cell responses and compared it with two other important costimulators, B7.1 (CD80) and 4-1BBL (CD137L). Delivery of OX40L to human monocytes using a recombinant replication-defective adenovirus led to greater expansion, up-regulation of perforin, enhanced cytolytic activity, and increased numbers of IFN-γ-and TNF-α-producing antiviral memory CD8 T cells in cultures of total T eels. Synergistic or additive effects were observed when OX40L costimulation was combined with 4-1BBL (CD137L) or B7.1 (CD80) costimulation. In total T cell cultures, at low Ag dose, 4-1BBL provided the most potent costimulus for influenza-specific CD8 T cell expansion, followed by B7.1 (CD80) and then OX40L. For isolated CD8 T cells, 4-1BBL was also the most consistent costimulator, followed by B7.1. In contrast, OX40L showed efficacy in direct activation of memory CD8 T cells in only one of seven donors. Thus, OX40L costimulates human antiviral memory CD8 T cell responses largely through indirect effects and can enhance anti-influenza, anti-EBV, and anti-HIV responses, particularly in combination with 4-1BBL or B7.
AB - CTL are important effectors of antiviral immunity. Designing adjuvants that can induce strong cytotoxic T cell responses in humans would greatly improve the effectiveness of an antiviral vaccination or therapeutic strategy. Recent evidence suggests that, in addition to its well-established role in costimulation of CD4 T cell responses, OX40L (CD134) can directly costimulate mouse CD8 T cells. In this study, we evaluated the role of OX40L in costimulation of human antiviral CD8 T cell responses and compared it with two other important costimulators, B7.1 (CD80) and 4-1BBL (CD137L). Delivery of OX40L to human monocytes using a recombinant replication-defective adenovirus led to greater expansion, up-regulation of perforin, enhanced cytolytic activity, and increased numbers of IFN-γ-and TNF-α-producing antiviral memory CD8 T cells in cultures of total T eels. Synergistic or additive effects were observed when OX40L costimulation was combined with 4-1BBL (CD137L) or B7.1 (CD80) costimulation. In total T cell cultures, at low Ag dose, 4-1BBL provided the most potent costimulus for influenza-specific CD8 T cell expansion, followed by B7.1 (CD80) and then OX40L. For isolated CD8 T cells, 4-1BBL was also the most consistent costimulator, followed by B7.1. In contrast, OX40L showed efficacy in direct activation of memory CD8 T cells in only one of seven donors. Thus, OX40L costimulates human antiviral memory CD8 T cell responses largely through indirect effects and can enhance anti-influenza, anti-EBV, and anti-HIV responses, particularly in combination with 4-1BBL or B7.
UR - http://www.scopus.com/inward/record.url?scp=27744446078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27744446078&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.175.10.6368
DO - 10.4049/jimmunol.175.10.6368
M3 - Article
C2 - 16272289
AN - SCOPUS:27744446078
SN - 0022-1767
VL - 175
SP - 6368
EP - 6377
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -